Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 5:14 pm Purchase | 13G | Pyxis Oncology, Inc. PYXS | PFIZER INC PFE | 5,221,176 14.88% | 2,229,654 (+74.53%) | View |
| 2023-02-13 5:06 pm Purchase | 13G | AN2 Therapeutics, Inc. ANTX | PFIZER INC PFE | 1,362,499 7.02% | 1,362,499 (New Position) | View |
| 2023-02-09 11:30 am Purchase | 13G | Pfizer Inc. PFE | VANGUARD GROUP INC | 501,636,220 8.94% | 36,361,295 (+7.82%) | View |
| 2023-02-07 1:11 pm Sale | 13G | Pfizer Inc. PFE | STATE STREET CORP STT | 284,943,697 5.08% | -827,894 (-0.29%) | View |
| 2023-02-03 4:27 pm Purchase | 13G | Pfizer Inc. PFE | BlackRock Inc. BLK | 442,868,761 7.9% | 32,883,116 (+8.02%) | View |
| 2023-02-01 5:06 pm Unchanged | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32% | 0 (Unchanged) | View |
| 2022-12-29 4:41 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | PFIZER INC PFE | 5,376,344 12% | 5,376,344 (New Position) | View |
| 2022-07-27 4:42 pm Purchase | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32% | 2,955,063,626 (New Position) | View |
| 2022-06-29 5:09 pm Purchase | 13G | Valneva SE VALN | PFIZER INC PFE | 9,549,761 8.1% | 9,549,761 (New Position) | View |
| 2022-06-28 4:19 pm Purchase | 13G | Akero Therapeutics, Inc. AKRO | PFIZER INC PFE | 2,525,252 6.7% | 2,525,252 (New Position) | View |
| 2022-04-07 4:51 pm Unchanged | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 18.5% | 0 (Unchanged) | View |
| 2022-04-07 4:11 pm Unchanged | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 15.4% | 0 (Unchanged) | View |
| 2022-03-21 4:25 pm Purchase | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 3,978,540 23.1% | 3,978,540 (New Position) | View |
| 2022-02-14 4:04 pm Purchase | 13G | eFFECTOR Therapeutics, Inc. EFTR | PFIZER INC PFE | 2,243,850 5.56% | 2,243,850 (New Position) | View |
| 2022-02-14 12:06 pm Purchase | 13G | Pfizer Inc. PFE | STATE STREET CORP STT | 285,771,591 5.09% | 5,940,218 (+2.12%) | View |
| 2022-02-11 7:01 pm Sale | 13G | SpringWorks Therapeutics, Inc. SWTX | PFIZER INC PFE | 2,340,330 4.75% | -2,242,717 (-48.94%) | View |
| 2022-02-11 6:06 pm Sale | 13G | Quince Therapeutics, Inc. QNCX | PFIZER INC PFE | 600,000 2.01% | -1,456,377 (-70.82%) | View |
| 2022-02-11 5:32 pm Unchanged | 13G | ContraFect Corporation CFRX | PFIZER INC PFE | 1,785,267 4.54% | 0 (Unchanged) | View |
| 2022-02-11 5:10 pm Unchanged | 13G | ESSA Pharma Inc. EPIX | PFIZER INC PFE | 1,675,000 3.81% | 0 (Unchanged) | View |
| 2022-02-11 4:55 pm Sale | 13G | BioAtla, Inc. BCAB | PFIZER INC PFE | 1,372,052 3.88% | -866,038 (-38.70%) | View |